Translation of amt-130 preclinical data to inform the design of the first fda-approved human aav gene therapy clinical trial in adults with early manifest huntington's disease

Category Primary study
JournalNeurology
Year 2020
This article has no abstract
Epistemonikos ID: b3d67e53f005121e6c571c8d0842b363bd1e99f2
First added on: Feb 12, 2025